WC
AMRI

Walthausen & Co’s Albany Molecular Research Inc AMRI Stock Holding History

Walthausen & Co’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-827,155
Closed -$17.9M – 127
2017
Q2 		$17.9M Sell
827,155
-4,130
-0.5% -$75K 1.76% 5
2017
Q1 		$11.7M Buy
831,285
+114,430
+16% +$1.87M 1.2% 27
2016
Q4 		$13.4M Buy
716,855
+607,575
+556% +$10.3M 1.25% 21
2016
Q3 		$1.8M Buy
+109,280
New +$1.62M 0.18% 109

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Walthausen & Co's AMRI Position: Q3 2017 in Review

Walthausen & Co sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 827,155 shares — an estimated $17.9M sold.

Walthausen & Co first reported a position in AMRI in Q3 2016 and held it in 4 quarters. The position peaked at $17.9M in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Walthausen & Co reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Walthausen & Co sold 827,155 Albany Molecular Research Inc shares in Q3 2017, an estimated $17.9M.
  • Walthausen & Co first reported a position in Albany Molecular Research Inc in Q3 2016 and held it in 4 quarters.
  • Walthausen & Co's Albany Molecular Research Inc position peaked at $17.9M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Walthausen & Co's 13F filing for Q3 2017, filed 15 Nov 2017.